Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02047734
Brief Title: Efficacy and Safety Study of Ozanimod in Relapsing Multiple Sclerosis (RADIANCE)

First Submitted : January 26, 2014
First Submitted that Met QC Criteria : January 26, 2014
First Posted : January 28, 2014 (Estimate)

Results First Submitted : January 25, 2021
Results First Submitted that Met QC Criteria : January 25, 2021
Results First Posted : February 11, 2021

Certification/Extension First Submitted : April 4, 2018
Certification/Extension First Submitted that Met QC Criteria : April 4, 2018
Certification/Extension First Posted : April 6, 2018

Last Update Submitted that Met QC Criteria : January 25, 2021
Last Update Posted : February 11, 2021